July 26 (Reuters) - The U.S. Food and Drug Administration
has enhanced warnings of side effects of a group of strong
antibiotics used to treat a variety of respiratory and urinary
tract infections and limited their use to patients with no
alternatives.
Read more
No comments:
Post a Comment